Taubert Jennifer L

SEC Form 4 insider
EVP, WWC. Innovative Medicine · JOHNSON & JOHNSON ($JNJ), MCDONALDS CORP ($MCD)
1 thesis · first seen Aug 18, 2026
WindowThesesResolvedWinsWin rateAvg returnMedian return
1d1100%+0.8%+0.8%
3d111100%-0.3%-0.3%
1w1100%+0.7%+0.7%
1m000———
3m000———
6m000———
1y000———

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$JNJSEC Form 4bearish
Sold 15,000 @ $263.36 avg · $3,950,400 · 2026-08-17

Form 4: Taubert Jennifer L sold JNJ

Taubert Jennifer L (EVP, WWC. Innovative Medicine at JOHNSON & JOHNSON) reported an open-market sale of 15,000 shares of JNJ at an average $263.36, roughly $3,950,400, in a Form 4 filed 2026-08-18.

At post $271.11Now $256.03-5.6% since postedas of Oct 2, 4:30 PM ET
1d+0.8%
3d-0.3%
1w+0.7%
1m-0.3%
3m—
6m—
1y—
View filing on SEC.gov →

End of results.